论文部分内容阅读
目的:分析比较妈富隆、妇康片治疗绝经过渡期功能性子宫出血的效果。方法:选取我院2016年5月至2017年5月收治的绝经过渡期功能性子宫出血患者92例,按照治疗方式不同分为妈富隆组和妇康片组,对比分析两组患者临床指标变化情况和治疗效果。结果:妈富隆组患者在出血量、出血显著减小时间、完全止血时间等临床指标中明显低于妇康片组患者,经统计学对比分析,P<0.05,差异显著,但妈富隆组患者治疗总有效率为95.65%,妇康片组患者治疗总有效率为86.95%,尽管妇康片组治疗效果稍低于妈富隆组,但两组统计学对比分析无意义(X~2=2.190,P=0.138>0.05)。结论:妈富隆治疗绝经过渡期功能性子宫出血患者的效果相对较好,临床治疗可着重作为治疗药物予以使用。
Objective: To analyze and compare the effect of Marvelon and Fukangpian in treating functional uterine bleeding during menopause. Methods: A total of 92 patients with functional uterine bleeding during the menopause transitional period from May 2016 to May 2017 in our hospital were selected. According to the different treatment methods, the patients were divided into two groups: Marvelon group and Fukangpian group. The changes of clinical indexes Situation and treatment effect. Results: The patients in Marvelon group had significantly lower bleeding time, complete bleeding time and other clinical indexes than those in the Fukang tablet group. The difference was significant (P <0.05) by statistical analysis, but the Marumont group patients The total effective rate of treatment was 95.65%. The total effective rate of treatment in the women group was 86.95%. Although the treatment effect of the women’s health group was slightly lower than that of the Marvelon group, the statistical comparative analysis between the two groups was insignificant (X 2 = 2.190 , P = 0.138> 0.05). Conclusion: Marvelon treatment of functional bleeding in postmenopausal transitional period patients with relatively good results, clinical treatment can be focused on as a therapeutic drug to be used.